Guardian Pharmacy Services, Inc. (GRDN)
| Market Cap | 1.35B |
| Revenue (ttm) | 1.17B |
| Net Income (ttm) | -98.09M |
| Shares Out | 63.29M |
| EPS (ttm) | -1.55 |
| PE Ratio | n/a |
| Forward PE | 25.53 |
| Dividend | n/a |
| Ex-Dividend Date | n/a |
| Volume | 121,939 |
| Open | 21.26 |
| Previous Close | 21.56 |
| Day's Range | 21.12 - 21.61 |
| 52-Week Range | 14.16 - 23.05 |
| Beta | n/a |
| Analysts | Strong Buy |
| Price Target | 22.50 (+5.78%) |
| Earnings Date | Nov 12, 2024 |
About GRDN
Guardian Pharmacy Services, Inc., a pharmacy service company, provides a suite of technology-enabled services designed to help residents of long-term health care facilities (LTCFs) in the United States. Its individualized clinical, drug dispensing, and administration capabilities are used to serve the needs of residents in lower acuity LTCFs, such as assisted living facilities and behavioral health facilities and group homes. The company’s Guardian Compass includes dashboards created using data from its data warehouse to help its local pharmaci... [Read more]
Financial Performance
In 2023, GRDN's revenue was $1.05 billion, an increase of 15.10% compared to the previous year's $908.91 million. Earnings were $23.90 million, a decrease of -32.52%.
Financial StatementsAnalyst Forecast
According to 2 analysts, the average rating for GRDN stock is "Strong Buy." The 12-month stock price forecast is $22.5, which is an increase of 5.78% from the latest price.
News
Guardian Pharmacy Services, Inc. Reports Third Quarter 2024 Financial Results
ATLANTA--(BUSINESS WIRE)--Guardian Pharmacy Services, Inc. (“Guardian”) (NYSE: GRDN), one of the nation's largest long-term care (LTC) pharmacy services companies, today announced financial results fo...
Guardian Pharmacy Services, Inc. to Participate in Upcoming Investor Conference
ATLANTA--(BUSINESS WIRE)--Guardian Pharmacy Services, Inc. (NYSE: GRDN), one of the nation's largest long-term care (LTC) pharmacy services companies, today announced that they will participate in the...
Guardian Pharmacy Services, Inc. to Report Third Quarter 2024 Financial Results and Host Conference Call
ATLANTA--(BUSINESS WIRE)--Guardian Pharmacy Services, Inc. (NYSE: GRDN), one of the nation's largest long-term care (LTC) pharmacy services companies, today announced that it will release its third qu...
Newly Listed Guardian Pharmacy Is Well Positioned In Highly Fragmented Market, Analyst Initiates With Buy Rating
Truist Securities has initiated coverage on Guardian Pharmacy Services, Inc GRDN, which operates long-term care pharmacies that facilitate the full lifecycle of pharmacy administration and associated ...
This GE Vernova Analyst Begins Coverage On A Bullish Note; Here Are Top 5 Initiations For Monday
Top Wall Street analysts changed their outlook on these top names. For a complete view of all analyst rating changes, including upgrades and downgrades, please see our analyst ratings page.
U.S. IPO Weekly Recap: 3 Sizable Deals Trade Up
Three IPOs each raised at least $100 million this week, in a welcome bump in activity. Four IPOs and two SPACs submitted initial filings this past week. Six IPOs are currently scheduled to list in the...
Guardian Pharmacy shares rise 3% in lukewarm NYSE debut
Guardian Pharmacy's shares rise 3.3% in their NYSE debut, giving the healthcare firm a market valuation of about $880 million.
Healthcare firm Guardian Pharmacy raises $112 mln in US IPO
Guardian Pharmacy, which provides pharmacy services to long-term healthcare facilities, raised $112 million in its U.S. initial public offering on Wednesday.
Guardian Pharmacy Services, Inc. Announces Pricing of Upsized Initial Public Offering
ATLANTA--(BUSINESS WIRE)--Guardian Pharmacy Services, Inc. (“Guardian”) today announced the pricing of its upsized initial public offering of 8,000,000 shares of Class A common stock at a public offer...
U.S. IPO Weekly Recap: 2 Microcaps List As Pipeline Gets A Big Boost
Two small IPOs and two SPACs debuted this past week - Global Engine, Kairos Pharma, YHN Acquisition I, and Cayson Acquisition, respectively. Seven IPOs and three SPACs submitted initial filings. Eight...
Guardian Pharmacy Services' IPO Valuation Looks Pricey
Guardian Pharmacy Services has filed proposed terms for a $101 million U.S. IPO. The company focuses on providing outsourced pharmacy services to long-term healthcare facilities, targeting assisted li...
Guardian Pharmacy targets up to $974 mln valuation in US IPO
Guardian Pharmacy Services said on Monday it was targeting a valuation as much as $973.5 million in its initial public offering in the United States.
Guardian Pharmacy Services Announces Launch of Initial Public Offering
ATLANTA--(BUSINESS WIRE)--Guardian Pharmacy Services, Inc. (“Guardian”) today announced the launch of its underwritten initial public offering of 6,750,000 shares of its Class A common stock pursuant ...
Guardian Pharmacy Services Expands Western Footprint Across Seven States Through Heartland Pharmacy Partnership
ATLANTA--(BUSINESS WIRE)--Guardian Pharmacy Services announces a major seven state expansion in the western U.S. through a partnership with Heartland Pharmacy.
Guardian Pharmacy Services Launches U.S. IPO Effort
Guardian Pharmacy Services, Inc. has filed for a $115 million IPO of its Class A common stock, although the final figure may differ. The company provides pharmacy services to patients in assisted livi...
Guardian Pharmacy Services IPO Registration Document (S-1)
Guardian Pharmacy Services has filed to go public with an IPO on the New York Stock Exchange (NYSE)